GKIM
BHVN icon

GW&K Investment Management’s Biohaven BHVN Stock Holding History

GW&K Investment Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2
Closed – – 925
2023
Q4 		$0 Hold
2
– – ﹤0.01% 930
2023
Q3 		$0 Hold
2
– – ﹤0.01% 913
2023
Q2 		$0 Hold
2
– – ﹤0.01% 900
2023
Q1 		$0 Sell
2
-19
-90% -$302 ﹤0.01% 481
2022
Q4 		$0 Buy
+21
New +$297 ﹤0.01% 457

Other funds holding BHVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

GW&K Investment Management's BHVN Position: Q1 2024 in Review

GW&K Investment Management sold out of Biohaven (BHVN) in Q1 2024, closing a stake of 2 shares.

GW&K Investment Management first reported a position in BHVN in Q4 2022 and held it in 5 quarters. The position peaked at $0 in Q4 2023. 243 funds tracked by Wall St. Rank hold BHVN as of Q1 2024.

  • GW&K Investment Management reported no remaining Biohaven position as of Q1 2024 after selling out during the quarter.
  • GW&K Investment Management sold 2 Biohaven shares in Q1 2024.
  • GW&K Investment Management first reported a position in Biohaven in Q4 2022 and held it in 5 quarters.
  • GW&K Investment Management's Biohaven position peaked at $0 in Q4 2023.
  • 243 funds tracked by Wall St. Rank held Biohaven as of Q1 2024.

Based on GW&K Investment Management's 13F filing for Q1 2024, filed 8 May 2024.